Showing results (421-430 of 447) with videos related to
Sort By:
Pageof 45
Nature Medicine|March 27, 2021
Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodiesDelphine Planas, Timothée Bruel, Ludivine Grzelak, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|July 30, 2016
Phenotypic Modulation of Smooth Muscle Cells in Atherosclerosis Is Associated With Downregulation of LMOD1, SYNPO2, PDLIM7, PLN, and SYNMLjubica Perisic Matic, Urszula Rykaczewska, Anton Razuvaev, et al.The Journal of Experimental Medicine|March 15, 2023
IFN-γ signature enables selection of neoadjuvant treatment in patients with stage III melanomaIrene L M Reijers, Disha Rao, Judith M Versluis, et al.Nature Genetics|February 10, 2015
The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapiesLuping Lin, Amit J Sabnis, Elton Chan, et al.Cell Reports|August 14, 2021
Differential effects of the second SARS-CoV-2 mRNA vaccine dose on T cell immunity in naive and COVID-19 recovered individualsDaniel Lozano-Ojalvo, Carmen Camara, Eduardo Lopez-Granados, et al.European Journal of Cancer (Oxford, England : 1990)|November 27, 2024
Impact of personalized response-directed surgery and adjuvant therapy on survival after neoadjuvant immunotherapy in stage III melanoma: Comparison of 3-year data from PRADO and OpACIN-neoIrene L M Reijers, Alexander M Menzies, Marta Lopez-Yurda, et al.Nature Medicine|September 22, 2022
Diet-driven microbial ecology underpins associations between cancer immunotherapy outcomes and the gut microbiomeRebecca C Simpson, Erin R Shanahan, Marcel Batten, et al.Journal for Immunotherapy of Cancer|March 25, 2025
FDG-PET associations with pathological response and survival with neoadjuvant immunotherapy for melanomaLi Zhou, Milton Jose Barros E Silva, Edward Hsiao, et al.NEJM Evidence|September 24, 2024
Sequencing of Checkpoint or BRAF/MEK Inhibitors on Brain Metastases in MelanomaPaolo A Ascierto, Mario Mandalà, Pier Francesco Ferrucci, et al.Nature Medicine|February 27, 2025
Neoadjuvant triplet immune checkpoint blockade in newly diagnosed glioblastomaGeorgina V Long, Elena Shklovskaya, Laveniya Satgunaseelan, et al.Pageof 45